查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1413135

下一代生物製造市場：按類型、應用和最終用戶分類 - 2024-2030 年全球預測

Next-Generation Biomanufacturing Market by Type, Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

下一代生物製造市場規模預計2023年為191億美元，2024年達到206.9億美元，預計2030年將達到349.7億美元，複合年成長率為9.02%。

下一代生物製造的全球市場

主要市場統計
基準年[2023] 191億美元
預測年份 [2024] 206.9億美元
預測年份 [2030] 349.7億美元
複合年成長率（%） 9.02%
下一代生物製造市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估下一代生物製造市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對下一代生物製造市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-下一代生物製造市場的市場規模與預測是多少？

2-在下一代生物製造市場的預測期內，需要考慮投資的產品、細分市場、應用和領域有哪些？

3-下一代生物製造市場的技術趨勢和法律規範是什麼？

4-下一代生物製造市場主要製造商的市場佔有率是多少？

5-進入下一代生物製造市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對生物製藥和基因療法的需求不斷成長
      • 生物製造對更大彈性和擴充性的需求日益成長
      • 採用流程自動化和連續製造
    • 抑制因素
      • 下一代生物製造成本高
    • 機會
      • 下一代生物製造的進展
      • 對下一代生物製造的重大投資
    • 任務
      • 下一代生物製造的技術挑戰
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章下一代生物製造市場：按類型

  • 持續的上游生物製造
  • 下游生物製造
  • 一次性上游生物製造

第7章下一代生物製造市場：依應用分類

  • 荷爾蒙
  • 單株抗體
  • 重組蛋白
  • 疫苗

第8章下一代生物製造市場：依最終用戶分類

  • 生物製藥公司
  • 契約製造組織
  • 調查機構

第9章美洲下一代生物製造市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區下一代生物製造市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的下一代生物製造市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第13章競爭產品組合

  • 主要公司簡介
    • Agilent Technologies, Inc.
    • Applikon Biotechnology BV
    • bbi-biotech GmbH
    • Biofluidica, Inc.
    • Danaher Corporation
    • Eppendorf AG
    • ESCO Group
    • Eurofins Scientific SE
    • GEA Group AG
    • GENEWIZ, Inc. by Azenta Life Sciences
    • Hamilton Company
    • Illumina, Inc.
    • Macrogen Inc.
    • Merck KGaA
    • Oxford Nanopore Technologies plc
    • PBS Biotech, Inc.
    • PerkinElmer Inc.
    • QIAGEN NV
    • Sartorius AG
    • Shanghai Bailun Biotechnology Co., Ltd.
    • Solaris Biotechnology Srl by DONALDSON ITALIA SRL
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
    • ZETA GmbH
    • Zymo Research Corporation
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-5C6F41F5B006

[191 Pages Report] The Next-Generation Biomanufacturing Market size was estimated at USD 19.10 billion in 2023 and expected to reach USD 20.69 billion in 2024, at a CAGR 9.02% to reach USD 34.97 billion by 2030.

Global Next-Generation Biomanufacturing Market

KEY MARKET STATISTICS
Base Year [2023] USD 19.10 billion
Estimated Year [2024] USD 20.69 billion
Forecast Year [2030] USD 34.97 billion
CAGR (%) 9.02%
Next-Generation Biomanufacturing Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Next-Generation Biomanufacturing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Next-Generation Biomanufacturing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Next-Generation Biomanufacturing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applikon Biotechnology BV, bbi-biotech GmbH, Biofluidica, Inc., Danaher Corporation, Eppendorf AG, ESCO Group, Eurofins Scientific SE, GEA Group AG, GENEWIZ, Inc. by Azenta Life Sciences, Hamilton Company, Illumina, Inc., Macrogen Inc., Merck KGaA, Oxford Nanopore Technologies plc, PBS Biotech, Inc., PerkinElmer Inc., QIAGEN N.V., Sartorius AG, Shanghai Bailun Biotechnology Co., Ltd., Solaris Biotechnology Srl by DONALDSON ITALIA S.R.L., Takara Bio Inc., Thermo Fisher Scientific Inc., ZETA GmbH, and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Next-Generation Biomanufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Continuous Upstream Biomanufacturing
    • Downstream Biomanufacturing
    • Single-Use Upstream Biomanufacturing
  • Application
    • Hormones
    • Monoclonal Antibodies
    • Recombinant Proteins
    • Vaccines
  • End-User
    • Biopharmaceutical Companies
    • Contract Manufacturing Organizations
    • Research Institutions
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Next-Generation Biomanufacturing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Next-Generation Biomanufacturing Market?

3. What are the technology trends and regulatory frameworks in the Next-Generation Biomanufacturing Market?

4. What is the market share of the leading vendors in the Next-Generation Biomanufacturing Market?

5. Which modes and strategic moves are suitable for entering the Next-Generation Biomanufacturing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Next-Generation Biomanufacturing Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for biopharmaceuticals and gene therapies
      • 5.1.1.2. Rising need to enhance flexibility and scalability of biomanufacturing
      • 5.1.1.3. Adoption of process automation and continuous manufacturing
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of next-generation biomanufacturing
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in next-generation biomanufacturing
      • 5.1.3.2. Significant investments in next-generation biomanufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Technical challenges in next-generation biomanufacturing
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Next-Generation Biomanufacturing Market, by Type

  • 6.1. Introduction
  • 6.2. Continuous Upstream Biomanufacturing
  • 6.3. Downstream Biomanufacturing
  • 6.4. Single-Use Upstream Biomanufacturing

7. Next-Generation Biomanufacturing Market, by Application

  • 7.1. Introduction
  • 7.2. Hormones
  • 7.3. Monoclonal Antibodies
  • 7.4. Recombinant Proteins
  • 7.5. Vaccines

8. Next-Generation Biomanufacturing Market, by End-User

  • 8.1. Introduction
  • 8.2. Biopharmaceutical Companies
  • 8.3. Contract Manufacturing Organizations
  • 8.4. Research Institutions

9. Americas Next-Generation Biomanufacturing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Next-Generation Biomanufacturing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Next-Generation Biomanufacturing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Agilent Technologies, Inc.
    • 13.1.2. Applikon Biotechnology BV
    • 13.1.3. bbi-biotech GmbH
    • 13.1.4. Biofluidica, Inc.
    • 13.1.5. Danaher Corporation
    • 13.1.6. Eppendorf AG
    • 13.1.7. ESCO Group
    • 13.1.8. Eurofins Scientific SE
    • 13.1.9. GEA Group AG
    • 13.1.10. GENEWIZ, Inc. by Azenta Life Sciences
    • 13.1.11. Hamilton Company
    • 13.1.12. Illumina, Inc.
    • 13.1.13. Macrogen Inc.
    • 13.1.14. Merck KGaA
    • 13.1.15. Oxford Nanopore Technologies plc
    • 13.1.16. PBS Biotech, Inc.
    • 13.1.17. PerkinElmer Inc.
    • 13.1.18. QIAGEN N.V.
    • 13.1.19. Sartorius AG
    • 13.1.20. Shanghai Bailun Biotechnology Co., Ltd.
    • 13.1.21. Solaris Biotechnology Srl by DONALDSON ITALIA S.R.L.
    • 13.1.22. Takara Bio Inc.
    • 13.1.23. Thermo Fisher Scientific Inc.
    • 13.1.24. ZETA GmbH
    • 13.1.25. Zymo Research Corporation
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. NEXT-GENERATION BIOMANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NEXT-GENERATION BIOMANUFACTURING MARKET DYNAMICS
  • FIGURE 7. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. NEXT-GENERATION BIOMANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. NEXT-GENERATION BIOMANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. NEXT-GENERATION BIOMANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS UPSTREAM BIOMANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM BIOMANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE UPSTREAM BIOMANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 10. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY HORMONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NEXT-GENERATION BIOMANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 146. NEXT-GENERATION BIOMANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. NEXT-GENERATION BIOMANUFACTURING MARKET LICENSE & PRICING